CompanyGraph
Eco Animal Health Group PLC
EAH · United Kingdom
ecoanimalhealth.comFinancials as of FY2025 · latest on file
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $87.85M, lower than 95% of all stocks globally
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2025 (year ended March 31, 2025). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
65.05MGBP87.85M · vs all stocks (USD)
Trailing P/E
31.83xRevenue (TTM)
87.53MGBP118.21M · vs all stocks (USD)
Profit Margin
2.50%Beta
-0.0050xvs all stocks
52-Week Change
28.63%vs all stocks
Market Capitalization
65.05MGBP87.85M · vs all stocks (USD)
Enterprise Value
52.62MGBP71.07M · vs all stocks (USD)
Trailing P/E
31.83xForward P/E
20.19xPrice to Sales (TTM)
0.7279xPrice to Book (MRQ)
0.7432xEnterprise to Revenue
0.6010xEnterprise to EBITDA
6.82xProfit Margin
2.50%Operating Margin
9.46%Return on Assets (TTM)
2.99%Return on Equity (TTM)
3.84%Revenue (TTM)
87.53MGBP118.21M · vs all stocks (USD)
Revenue per Share (TTM)
1.30GBPUpdated Jul 29, 2026Quarterly Revenue Growth
3.70%Gross Profit (TTM)
42.50MGBP57.39M · vs all stocks (USD)
EBITDA (TTM)
6.34MGBP8.56M · vs all stocks (USD)
Net Income (TTM)
2.19MGBP2.96M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-24.50%Operating Cash Flow (TTM)
7.66MGBP10.34M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
5.34MGBP7.21M · vs all stocks (USD)
5-Year Average Dividend Yield
2.45%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
9.27MGBPFY2025 · Mar 31, 2025Revenue
79.60MGBPFY2025 · Mar 31, 2025Cost of Goods Sold
43.68MGBPFY2025 · Mar 31, 2025Gross Profit
35.91MGBPFY2025 · Mar 31, 2025Operating Income
3.35MGBP4.52M · vs all stocks (USD)
Pre-tax Income
4.01MGBPFY2025 · Mar 31, 2025Income Tax Expense
1.38MGBPFY2025 · Mar 31, 2025Net Income
2.63MGBPFY2025 · Mar 31, 2025EBIT
4.46MGBPFY2025 · Mar 31, 2025EBITDA (Income Statement)
6.34MGBPFY2025 · Mar 31, 2025Research & Development
3.99MGBPFY2025 · Mar 31, 2025Selling, General & Administrative
28.73MGBPFY2025 · Mar 31, 2025Non-operating Interest Income
110.00KGBPFY2025 · Mar 31, 2025Non-operating Interest Expense
452.00KGBPFY2025 · Mar 31, 2025EPS (Basic)
0.0249GBPFY2025 · Mar 31, 2025EPS (Diluted)
0.0243GBPFY2025 · Mar 31, 2025Basic Shares Outstanding
67.63MSharesFY2025 · Mar 31, 2025Diluted Shares Outstanding
67.63MSharesFY2025 · Mar 31, 2025Minority Interests (P&L)
-948.00KGBPFY2025 · Mar 31, 2025Preferred Stock Dividends
0.00GBPFY2025 · Mar 31, 2025Operating Cash Flow
10.04MGBPFY2025 · Mar 31, 2025Free Cash Flow
9.69MGBPFY2025 · Mar 31, 2025Cash & Cash Equivalents (End of Period)
25.01MGBPFY2025 · Mar 31, 2025Starting Profit (CF Statement)
4.01MGBPFY2025 · Mar 31, 2025Stock-based Compensation
401.00KGBPFY2025 · Mar 31, 2025Other Non-cash Items
-612.00KGBPFY2025 · Mar 31, 2025Change in Accounts Receivable (CF)
4.16MGBPFY2025 · Mar 31, 2025Change in Other Assets/Liabilities
2.09MGBPFY2025 · Mar 31, 2025Capital Expenditures
-356.00KGBPFY2025 · Mar 31, 2025Net Intangibles (CF)
-4.65MGBPFY2025 · Mar 31, 2025Net Acquisitions
288.00KGBPFY2025 · Mar 31, 2025Net Investing Cash Flow
-68.00KGBPFY2025 · Mar 31, 2025Common Dividends Paid
-1.06MGBPFY2025 · Mar 31, 2025Net Financing Cash Flow
-1.06MGBPFY2025 · Mar 31, 2025Shares Outstanding
66.71MSharesUpdated Jul 29, 2026Float Shares
59.27MSharesUpdated Jul 29, 2026% Held by Insiders
11.81%vs all stocks
% Held by Institutions
70.57%vs all stocks
Total Cash (MRQ)
25.43MGBP34.35M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3750GBPUpdated Jul 29, 2026Total Debt (MRQ)
4.93MGBP6.66M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0517xCurrent Ratio (MRQ)
3.42xBook Value per Share (MRQ)
1.28GBPUpdated Jul 29, 2026Total Assets
120.60MGBP162.88M · vs all stocks (USD)
Total Current Assets
69.94MGBPFY2025 · Mar 31, 2025Total Liabilities
25.84MGBPFY2025 · Mar 31, 2025Total Non-current Assets
50.66MGBPFY2025 · Mar 31, 2025Total Non-current Liabilities
4.03MGBPFY2025 · Mar 31, 2025Total Current Liabilities
21.81MGBPFY2025 · Mar 31, 2025Cash & Cash Equivalents
25.01MGBPFY2025 · Mar 31, 2025Accounts Receivable
25.43MGBPFY2025 · Mar 31, 2025Inventory
14.55MGBPFY2025 · Mar 31, 2025Accounts Payable
9.79MGBPFY2025 · Mar 31, 2025Short-term Debt
621.00KGBPFY2025 · Mar 31, 2025Long-term Debt
3.16MGBPFY2025 · Mar 31, 2025Common Stock (Book)
3.39MGBPFY2025 · Mar 31, 2025Retained Earnings
17.87MGBPFY2025 · Mar 31, 2025Total Shareholders' Equity
94.77MGBP127.98M · vs all stocks (USD)
Treasury Stock
204.00KGBPFY2025 · Mar 31, 202552-Week Low
72.00GBXUpdated Jul 29, 202652-Week High
116.90GBXUpdated Jul 29, 202652-Week Change
28.63%vs all stocks
Beta
-0.0050xvs all stocks
50-Day MA
91.89GBXUpdated Jul 29, 2026200-Day MA
96.76GBXUpdated Jul 29, 2026Avg 10-Day Volume
334.84KSharesUpdated Jul 29, 2026Avg 30-Day Volume
178.52KSharesUpdated Jul 29, 2026Diluted EPS (TTM)
0.0300GBPUpdated Jul 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $87.85M, lower than 95% of all stocks globallySignificant
Market cap (USD): 87,848,031.831Global P5: 275,556,405.438
Companies that share the same coordination system — how they create, deliver, or capture value.
Creo Medical Group plc
Tier 1ProductionApproval-Gated PipelineRule
Curiosis Inc.
Tier 1ProductionApproval-Gated PipelineRule
Poolbeg Pharma plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tenax Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Bonus BioGroup Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Y-Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Kala Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Faron Pharmaceuticals Oy
Tier 1ProductionApproval-Gated PipelineRuleRisk
Engene Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRule
Polaryx Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule